Home  »  News  »  Company News
Innovation · Full‑dimensional · Leadership — Century Healthcare’s Full‑dimensional Ocular Care System Banner 单行版(海报 / 标题栏直接使用)
Release:2025-05-21 Source:Company News Browse:8


Breaking the Cocoon · Setting Off (2008‑2015)

— The First Seed Sown for Bright Vision

2--------.png

At that time, China’s high‑end ophthalmic consumables market was still dominated by imported brands. Driven by the original aspiration of “enabling Chinese patients to access high‑quality domestic intraocular lenses”, a group of vision‑pursuing pioneers embarked on an arduous journey from zero to one.

4老厂房.png


5老照片.png



6厂房右面上.png


7厂房右下.png
8-----4条.png

  Deep Cultivation · Breakthrough (2015‑2020)

— Shattering Technical Barriers, Forging the Glory of Domestic Innovation

8-----4条.png

In 2020, Century Healthcare broke the monopoly of foreign brands by obtaining the Class‑III medical device registration certificate for its hydrophilic spherical intraocular lens, and was included in the volume‑based procurement catalogue covering the Beijing‑Tianjin‑Hebei 3+6 Provinces Alliance and Shaanxi Province, totaling ten provincial alliances. Ranging from intraocular lenses to injectors and surgical scalpels, the company built one of China’s few full‑range solution portfolios for cataract surgery that year, making “Made in China” a source of confidence for ophthalmologists.

8-----4条.png

 Leap · Metamorphosis (2021‑2023)

— Accelerating Innovation, Ushering in a Golden Era

8-----4条.png

Amid steady accumulation and breakthrough delivery,

Hydrophilic aspheric IOLs and the new‑generation hydrophobic aspheric IOLs (pre‑loaded & non‑pre‑loaded) were successively launched.

The trifocal IOL obtained the NMPA Innovative Medical Device designation, and in the same year won support from the “Tianjin Central‑Guided Local Science and Technology Development Fund Project”.

In 2023, the full product portfolio won bids in the National Volume‑Based Procurement…

With substantial capital injections from state‑owned investment funds including Haihe Fund and Yifeng Capital, the national brand set sail on its journey toward IPO.


12.png
13--2021.3.jpg

Mar. 2021 | China‑first IOL with Open‑loop Haptics & 6.25 mm Large‑Optical‑Zone Launched

Jul. 2023 | New‑Generation Hydrophobic Pre‑loaded Aspheric IOL Launched


14-2023.10.jpg
15--疏水国采成功中标(红色图).png

Nov. 2023 | Full IOL Portfolio Awarded Bid in 4th National Volume‑Based Procurement for High‑Value Consumables

Oct. 2023 | Trifocal IOL Granted NMPA Innovative Medical Device Designation

16-药监局评审中心.png

17&18.png

Breakthrough · Innovation (2024)

— Defining New Industry Benchmarks

17&18.png

In this year, Century Healthcare was awarded the national‑level "Specialized, Refined, Differential and Innovative Little Giant" enterprise certification, opening a new chapter of high‑quality development.

The Extended Depth‑of‑Focus (EDOF) IOL obtained the NMPA Innovative Medical Device designation, and also received support from the “Tianjin Major Special Project for Public Health and Biomedicine Science and Technology” in the same year.

Meishiji®, China‑first second‑generation aspheric scleral lens, made its remarkable debut.

The “Tianjin Key Laboratory of Innovative Ophthalmic Optical Technologies” was officially approved.

All these mark Century Healthcare’s qualitative transformation from “manufacturing” to “smart‑manufacturing”!


昭示着世纪康泰从"制造"向"智造"的质变。

19重磅喜讯红色图.png
20-药监局评审中心.jpg

Apr. 2024 | Extended Depth‑of‑Focus (EDOF) IOL Granted NMPA Innovative Medical Device Designation

21-巩膜镜.jpg

Aug. 2024 | China‑first 2nd‑Generation Aspheric Scleral Lens Launched



22-小巨人铜牌.jpg

Sep. 2024 | Awarded MIIT "Specialized, Refined, Differential and Innovative Little Giant" Title

23重点实验室.jpg

Dec. 2024 | Tianjin Key Laboratory of Innovative Ophthalmic Optical Technologies Officially Approved

24&25---.png

Full‑dimensional · Leadership (2025)

— Building the Great Wall of Eye‑Health Ecosystem

24&25---.png

With the launch of the world‑first Trifocal‑Plus intraocular lens, Century Healthcare’s Full‑dimensional Ophthalmic Care System has achieved a structural leap. Ranging from inclusive‑access intraocular lenses to premium Trifocal‑Plus and EDOF IOLs, and covering cataract surgery, refractive correction and optometric intervention, Century Healthcare has built a full‑cycle product matrix spanning “prevention‑treatment‑rehabilitation”. As defocus lenses, scleral lenses and orthokeratology lenses jointly form an optometric protection network, Century Healthcare delivers three‑dimensional, whole‑life‑cycle eye‑health protection for Chinese people.

1

Cataract Product Series

26三焦点.png

Trifocal‑Plus Intraocular Lens

27 EDOF.png

EDOF IOL

28大焦深.png

Refractive EDOF

Mono‑focus IOL Series

29滑动1.jpg
29滑动2.jpg
29滑动3.jpg
29滑动4.jpg
29滑动5.jpg
30-1手术刀.jpg
30-2推注器.jpg
30-3导入头.jpg

2

Optometry Product Series

31-美世纪.jpg
32-美世纪下左上.jpg
32-美世纪下左下.jpg
32-美世纪下右上.jpg
32-美世纪下右下.jpg
33&34.png

Future · Arrived

— Let the World Witness the Light of China

33&34.png

From the faint glow of the very first intraocular lens to a stellar product landscape safeguarding the eye‑health of 1.4 billion people, Century Healthcare measures time with dedication and defines the future through innovation. When every brightened vision across the globe bears the imprint of Chinese ingenuity, it stands as the finest tribute to all those who stay committed to their mission.


35新厂房.jpg
36--结束.png